{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:10:50Z","timestamp":1760825450641,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jocn.2021.06.006","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T04:55:28Z","timestamp":1624251328000},"page":"273-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Association between homocysteine and third ventricle dilatation, mesencephalic area atrophy in Parkinson\u2019s disease with cognitive impairment"],"prefix":"10.1016","volume":"90","author":[{"given":"Xin Yu","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Wei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Jing","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng Jie","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jocn.2021.06.006_b0005","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/01.wnl.0000306632.43729.24","article-title":"Dementia and survival in Parkinson disease: a 12-year population study","volume":"70","author":"Buter","year":"2008","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jocn.2021.06.006_b0010","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1212\/WNL.54.8.1596","article-title":"A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease","volume":"54","author":"Hughes","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jocn.2021.06.006_b0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.006_b0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mds.25798","article-title":"Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease","volume":"29","author":"Sapkota","year":"2014","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"issue":"7","key":"10.1016\/j.jocn.2021.06.006_b0025","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/nu9070725","article-title":"Plasma homocysteine and serum folate and vitamin B(12) levels in mild cognitive impairment and alzheimer's disease: a case-control study","volume":"9","author":"Ma","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jocn.2021.06.006_b0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JPD-181535","article-title":"Urate and homocysteine: predicting motor and cognitive changes in newly diagnosed Parkinson's disease","volume":"9","author":"Sleeman","year":"2019","journal-title":"J Parkinson's Dis"},{"issue":"7","key":"10.1016\/j.jocn.2021.06.006_b0035","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/1567205016666190725144629","article-title":"Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design","volume":"16","author":"Ma","year":"2019","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.006_b0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.45.1.182","article-title":"Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography","volume":"45","author":"Becker","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.06.006_b0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.09.032","article-title":"Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study","volume":"68","author":"Alonso-Canovas","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.006_b0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10072-015-2350-7","article-title":"Alteration of brainstem raphe measured by transcranial sonography in depression patients with or without Parkinson's disease","volume":"37","author":"Zhang","year":"2016","journal-title":"Neurol Sci: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"10","key":"10.1016\/j.jocn.2021.06.006_b0055","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s10072-017-3059-6","article-title":"Transcranial sonography image characteristics in different Parkinson's disease subtypes","volume":"38","author":"Sheng","year":"2017","journal-title":"Neurol Sci: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"key":"10.1016\/j.jocn.2021.06.006_b0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2019.07.005","article-title":"Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease","volume":"66","author":"Behnke","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2021.06.006_b0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2009.02.330","article-title":"Vascular characteristics of patients with dementia","volume":"283","author":"Morovi\u0107","year":"2009","journal-title":"J Neurol Sci"},{"issue":"19","key":"10.1016\/j.jocn.2021.06.006_b0070","first-page":"2291","article-title":"Transcranial sonographic alterations of substantia nigra and third ventricle in parkinson's disease with or without dementia","volume":"130","author":"Dong","year":"2017","journal-title":"Chin Med J"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.006_b0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-004-0265-y","article-title":"Determination of ventricular diameters in multiple sclerosis patients with transcranial sonography (TCS)\u2013a two year follow-up study","volume":"251","author":"Kallmann","year":"2004","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.jocn.2021.06.006_b0080","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.006_b0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"key":"#cr-split#-10.1016\/j.jocn.2021.06.006_b0090.1","doi-asserted-by":"crossref","unstructured":"Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 22 (12):1689-1707","DOI":"10.1002\/mds.21507"},{"key":"#cr-split#-10.1016\/j.jocn.2021.06.006_b0090.2","doi-asserted-by":"crossref","unstructured":"quiz 1837. doi:10.1002\/mds.21507","DOI":"10.1002\/mds.21507"},{"issue":"5","key":"10.1016\/j.jocn.2021.06.006_b0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.006_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.21198","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"key":"10.1016\/j.jocn.2021.06.006_b0105","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12 (3):189\u2013198","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"15","key":"10.1016\/j.jocn.2021.06.006_b0110","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.006_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ultrasmedbio.2006.07.021","article-title":"Transcranial brain parenchyma sonography in movement disorders: state of the art","volume":"33","author":"Walter","year":"2007","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jocn.2021.06.006_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000366238","article-title":"Parenchymal imaging in movement disorders","volume":"36","author":"Fernandes Rde","year":"2015","journal-title":"Front Neurol Neurosci"},{"key":"10.1016\/j.jocn.2021.06.006_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105383","article-title":"Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy","volume":"183","author":"Ghourchian","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"10.1016\/j.jocn.2021.06.006_b0130","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"PNAS"},{"issue":"13","key":"10.1016\/j.jocn.2021.06.006_b0135","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","article-title":"Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia","volume":"580","author":"Obeid","year":"2006","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.006_b0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pscychresns.2010.09.010","article-title":"Width of the third ventricle assessed by transcranial sonography can monitor brain atrophy in a time- and cost-effective manner\u2013results from a longitudinal study on 500 subjects","volume":"191","author":"Wollenweber","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jocn.2021.06.006_b0145","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.jocn.2021.06.006_b0150","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/mds.20652","article-title":"Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging","volume":"20","author":"Burton","year":"2005","journal-title":"Mov Disord: Off J Mov Disord Soc"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821003015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821003015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:29:03Z","timestamp":1760822943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821003015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":31,"alternative-id":["S0967586821003015"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.06.006","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between homocysteine and third ventricle dilatation, mesencephalic area atrophy in Parkinson\u2019s disease with cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}